JPH0564942B2 - - Google Patents

Info

Publication number
JPH0564942B2
JPH0564942B2 JP60502561A JP50256185A JPH0564942B2 JP H0564942 B2 JPH0564942 B2 JP H0564942B2 JP 60502561 A JP60502561 A JP 60502561A JP 50256185 A JP50256185 A JP 50256185A JP H0564942 B2 JPH0564942 B2 JP H0564942B2
Authority
JP
Japan
Prior art keywords
methyl
phenyl
fluoro
mol
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60502561A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61502259A (ja
Inventor
Zorutan Ekuserii
Yozusefu Kunooru
Eba Somufuei
Zorutan Toorooku
Eba Sujiniei
Karorii Mozusorikusu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinoin Private Co Ltd
Original Assignee
Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt filed Critical Chinoin Gyogyszer es Vegyeszeti Termekek Gyara Zrt
Publication of JPS61502259A publication Critical patent/JPS61502259A/ja
Publication of JPH0564942B2 publication Critical patent/JPH0564942B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
JP60502561A 1984-05-31 1985-05-31 新しい医薬品およびその製剤 Granted JPS61502259A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU2124/84 1984-05-31
HU842124A HU207282B (en) 1984-05-31 1984-05-31 Process for producing phenyl-alkyl-amine derivatives and pharmaceutical compositions containing them

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP5005262A Division JPH0819057B2 (ja) 1984-05-31 1993-01-14 新規なフェニルプロピニルアミン誘導体の製造法

Publications (2)

Publication Number Publication Date
JPS61502259A JPS61502259A (ja) 1986-10-09
JPH0564942B2 true JPH0564942B2 (en, 2012) 1993-09-16

Family

ID=10957881

Family Applications (2)

Application Number Title Priority Date Filing Date
JP60502561A Granted JPS61502259A (ja) 1984-05-31 1985-05-31 新しい医薬品およびその製剤
JP5005262A Expired - Lifetime JPH0819057B2 (ja) 1984-05-31 1993-01-14 新規なフェニルプロピニルアミン誘導体の製造法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP5005262A Expired - Lifetime JPH0819057B2 (ja) 1984-05-31 1993-01-14 新規なフェニルプロピニルアミン誘導体の製造法

Country Status (23)

Country Link
US (2) US5008292A (en, 2012)
EP (1) EP0186680B1 (en, 2012)
JP (2) JPS61502259A (en, 2012)
AT (1) AT394552B (en, 2012)
AU (1) AU588757B2 (en, 2012)
BG (1) BG61318B2 (en, 2012)
CH (1) CH671574A5 (en, 2012)
CS (1) CS271313B2 (en, 2012)
DD (1) DD235065A5 (en, 2012)
DE (2) DE3590241C2 (en, 2012)
DK (1) DK166018C (en, 2012)
ES (2) ES8609204A1 (en, 2012)
FI (1) FI92053C (en, 2012)
GB (1) GB2171694B (en, 2012)
GE (3) GEP19970818B (en, 2012)
HU (1) HU207282B (en, 2012)
IL (1) IL75358A (en, 2012)
MX (1) MX9203090A (en, 2012)
PL (2) PL150477B1 (en, 2012)
PT (1) PT80574B (en, 2012)
SE (1) SE463261B (en, 2012)
SU (3) SU1487810A3 (en, 2012)
WO (1) WO1985005617A1 (en, 2012)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3582060D1 (de) * 1984-11-22 1991-04-11 Sandoz Ag Homopropargylamine.
US5225446A (en) * 1990-08-31 1993-07-06 Deprenyl Animal Health, Inc. Use of 1-deprenyl for retention of specific physiological functions
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
US5767164A (en) * 1991-04-04 1998-06-16 Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
IL99759A (en) * 1991-10-16 1997-06-10 Teva Pharma Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
HUT63579A (en) * 1991-12-20 1993-09-28 Chinoin Gyogyszer Es Vegyeszet Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
US5169536A (en) * 1992-04-28 1992-12-08 Betz Laboratories, Inc. Detoxification agents for surfactant based biocides
IES940271A2 (en) * 1993-12-16 1994-11-16 Russinsky Ltd "A process for producing pharmaceutical compounds"
US5516747A (en) * 1994-04-18 1996-05-14 Henkel Corporation Pesticidal surfactant mixtures comprising alkyl polyglycosides and alkyl naphthalene sulfonates
CA2191996A1 (en) * 1994-06-03 1995-12-14 Thejmde Trust Meta substituted arylalkylamines and therapeutic and diagnostic uses thereof
HU218927B (hu) * 1994-11-22 2000-12-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Eljárás propargil-ammónium-klorid-származékok előállítására
AU723047B2 (en) 1995-02-10 2000-08-17 University Of Toronto Innovations Foundation, The Deprenyl compounds for treatment of glaucoma
JP3087891B2 (ja) 1998-03-31 2000-09-11 東洋紡績株式会社 電解質測定用試薬組成物
HUP9902482A2 (hu) * 1999-07-22 2002-04-29 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. P-fluoro-selegilin alkalmazása neuroprotektív gyógyszerkészítmények előállítására
CA2616918A1 (en) * 2005-07-01 2007-01-11 Jenrin Discovery Mao-b inhibitors useful for treating obesity
EP2053033A1 (en) * 2007-10-26 2009-04-29 Bayer Schering Pharma AG Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
CN102180798B (zh) * 2011-03-18 2013-11-06 湖北汉星化工新材料有限公司 一步法催化合成n,n-二乙基丙炔胺的方法
WO2015087094A1 (en) * 2013-12-10 2015-06-18 Semmelweis Egyetem New arylalkenylpropargylamine derivatives exhibiting neuroprotective action for the treatment of neurodegenerative diseases

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1311843A (fr) * 1961-09-06 1962-12-14 Abbott Lab Procédé de préparation de nu-halobenzyl-nu-méthyl-2-propynylamines
US3142554A (en) * 1961-10-10 1964-07-28 Monsanto Co Controlling vegetation with aryl thioalkylamines
GB1027611A (en) * 1962-01-04 1966-04-27 May & Baker Ltd Phenoxy- and phenylthio-alkylamines and acid addition salts thereof
DE1227447B (de) * 1962-03-30 1966-10-27 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Phenylisopropylaminen
GB1031425A (en) * 1962-03-30 1966-06-02 Chinoin Gyogyszer Es Vegyeszet New aralkylamines and their preparation
GB1121857A (en) * 1965-01-05 1968-07-31 Science Union & Cie New phenylisopropylamine derivatives and process for their preparation and pharmaceutical preparations of such derivatives
CH551943A (en) * 1965-02-08 1974-07-31 Chinoin Gyogyszer Es Vegyeszet N-(Lower alkyl)-phenylisopropylamines
US3485874A (en) * 1966-05-04 1969-12-23 Chinoin Gyogyszer Es Vegyeszet Ortho and para bromophenyl isopropyl methylamines
US3496195A (en) * 1966-05-11 1970-02-17 Chinoin Gyogyszer Es Vegyeszet D-o-bromo-phenyl-isopropyl-methylpropinylamine and its salts
US4137328A (en) * 1970-07-18 1979-01-30 Pfizer Inc. Phenyl-alkanolamine, alkylamine and α-aminoalkyl ketone derivatives as heart stimulants
US3689504A (en) * 1970-12-24 1972-09-05 Abbott Lab N-substituted -alpha-methyl-3,4-(methylenedioxy) phenethylamines
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
US4105695A (en) * 1975-12-11 1978-08-08 Bristol-Myers Company 2-Amino-1-(2,5-dimethoxyphenyl)-butanes
US4156017A (en) * 1977-02-22 1979-05-22 Schering Aktiengesellschaft Pesticides
US4200654A (en) * 1978-11-24 1980-04-29 Abbott Laboratories Ovicides
FR2486074A1 (fr) * 1979-12-14 1982-01-08 Lafon Labor Derives de fluorophenacyl-amine, leur procede de preparation et leur application en therapeutique

Also Published As

Publication number Publication date
SU1549477A3 (ru) 1990-03-07
IL75358A (en) 1988-10-31
EP0186680B1 (en) 1988-03-30
GEP19960459B (en) 1996-07-15
JPS61502259A (ja) 1986-10-09
ES544400A0 (es) 1986-09-01
ES8609204A1 (es) 1986-09-01
AU588757B2 (en) 1989-09-21
GB8602394D0 (en) 1986-03-05
PL150477B1 (en) 1990-05-31
MX9203090A (es) 1992-07-01
AU4437585A (en) 1985-12-31
DK45786D0 (da) 1986-01-30
SE8600413D0 (sv) 1986-01-30
ES552827A0 (es) 1987-04-16
FI860101A0 (fi) 1986-01-09
AT394552B (de) 1992-05-11
DE3590241C2 (en, 2012) 1991-08-01
DE3590241T (de) 1986-06-26
HU207282B (en) 1993-03-29
FI92053B (fi) 1994-06-15
GEP19970786B (en) 1997-01-20
SU1609443A3 (ru) 1990-11-23
FI92053C (fi) 1994-09-26
JPH0687798A (ja) 1994-03-29
PT80574B (pt) 1987-08-19
EP0186680A1 (en) 1986-07-09
CS389585A2 (en) 1989-12-13
CH671574A5 (en, 2012) 1989-09-15
BG61318B2 (bg) 1997-05-30
SE8600413L (sv) 1986-01-30
GEP19970818B (en) 1997-01-30
DK45786A (da) 1986-01-30
HUT37385A (en) 1985-12-28
ES8704445A1 (es) 1987-04-16
SU1487810A3 (ru) 1989-06-15
JPH0819057B2 (ja) 1996-02-28
PL253737A1 (en) 1987-02-23
SE463261B (sv) 1990-10-29
FI860101L (fi) 1986-01-09
US5008292A (en) 1991-04-16
WO1985005617A1 (en) 1985-12-19
DD235065A5 (de) 1986-04-23
CS271313B2 (en) 1990-09-12
US4960797A (en) 1990-10-02
PL149288B1 (en) 1990-01-31
DK166018C (da) 1993-07-12
ATA901585A (de) 1991-10-15
GB2171694A (en) 1986-09-03
GB2171694B (en) 1987-12-09
PT80574A (en) 1985-06-01
DK166018B (da) 1993-03-01

Similar Documents

Publication Publication Date Title
JPH0564942B2 (en, 2012)
US4476136A (en) Aminomethyl-5 oxazolidinic derivatives and therapeutic use thereof
JPS5939418B2 (ja) アリ−ルオキシフエニルプロピルアミン類の製法
JPS638935B2 (en, 2012)
US4034113A (en) Treatment of senile geriatric patients to restore performance
US4699928A (en) Fluoroallylamine derivatives
EP0168013B1 (en) Fluoroallylamine derivatives
JPS6033424B2 (ja) フェニルエチルアミンの誘導体、その製造方法およびフェニルエチルアミンの誘導体を有効成分とする高血圧および心臓血管病の治療薬
JPH04503819A (ja) 新規な二環式アミノ―置換化合物
JPS61165324A (ja) 心臓脈管系疾患治療剤
JPH08501285A (ja) Ｎ−シクロアルキルピペラジン誘導体、それらを取得する方法およびそれらを含有する薬学的組成物
FI61182B (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva butylaminderivat
FR2559771A1 (fr) Derives de la 3-pyrrolidinopropiophenone et procede pour leur preparation
CA1245673A (en) Medicine and its preparation
HU178147B (en) Process for producing hexahydro-1,4-oxazepines
CA1190242A (en) 2-amino-3-hydroxyphenyl-3-butenoic acid derivatives
US4101676A (en) Diphenylpropylamines to treat depression
CS271341B2 (en) Method of n-/4-fluorphenyl/-1-methyl/ethyl-n-methyl-n-propinylamine production
JPS638933B2 (en, 2012)
KR800001545B1 (ko) 피롤리딘 유도체의 제조방법
KR800001009B1 (ko) 아릴옥시페닐프로필 아민류의 제조방법
FR2539739A1 (fr) Nouveaux derives de la naphtyl pyridazine actifs sur le systeme nerveux central, procede de preparation de ces derives et medicaments en contenant
JPH0521898B2 (en, 2012)
JPS61140549A (ja) １０，１１‐ジヒドロ‐５Ｈ‐ジベンゾ〔ａ，ｄ〕シクロヘプタジエン誘導体、その製法及び該化合物を含有する薬剤
BE898221A (fr) Dérivés d'azepino (1,2-a) pyrimidine bronchodilatateurs, leurs sels d'addition d'acides et compositions pharmaceutiques qui les contiennent.